Synonyms: AZ 628 | AZ-628
Compound class:
Synthetic organic
Comment: AZ628 is an experimental inhibitor of RAF kinases [1]. Preclinical data for AZ628 was presented at the AACR Annual Meeting by Shen et al. in 2007 (Linking molecular characteristics to the pharmacological response of a panel of cancer cell lines to the BRAF inhibitor, AZ628).
|
|
References |
1. Khazak V, Astsaturov I, Serebriiskii IG, Golemis EA. (2007)
Selective Raf inhibition in cancer therapy. Expert Opin Ther Targets, 11 (12): 1587-609. [PMID:18020980] |
2. Kolch W, Kotwaliwale A, Vass K, Janosch P.
The role of Raf kinases in malignant transformation. Accessed on 24/06/2015. Modified on 24/06/2015. www.expertreviews.org, http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.114.8626&rep=rep1&type=pdf |
3. Wenglowsky S, Ren L, Grina J, Hansen JD, Laird ER, Moreno D, Dinkel V, Gloor SL, Hastings G, Rana S et al.. (2014)
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase. Bioorg Med Chem Lett, 24 (8): 1923-7. [PMID:24675381] |